FC
Fulcrum Capital’s Vertex Pharmaceuticals VRTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.03M | Buy |
15,798
+220
| +1% | +$97.9K | 1.49% | 24 |
|
|
2025
Q1 | $7.55M | Buy |
15,578
+84
| +0.5% | +$40.7K | 1.67% | 20 |
|
|
2024
Q4 | $6.24M | Buy |
15,494
+108
| +0.7% | +$43.5K | 1.31% | 26 |
|
|
2024
Q3 | $7.16M | Sell |
15,386
-10
| -0.1% | -$4.65K | 1.56% | 26 |
|
|
2024
Q2 | $7.22M | Buy |
15,396
+202
| +1% | +$94.7K | 1.64% | 24 |
|
|
2024
Q1 | $6.35M | Buy |
15,194
+123
| +0.8% | +$51.4K | 1.51% | 24 |
|
|
2023
Q4 | $6.13M | Sell |
15,071
-820
| -5% | -$334K | 1.59% | 24 |
|
|
2023
Q3 | $5.53M | Sell |
15,891
-60
| -0.4% | -$20.9K | 1.6% | 21 |
|
|
2023
Q2 | $5.61M | Sell |
15,951
-713
| -4% | -$251K | 1.48% | 25 |
|
|
2023
Q1 | $5.25M | Buy |
16,664
+3,033
| +22% | +$956K | 1.41% | 29 |
|
|
2022
Q4 | $3.94M | Buy |
13,631
+10,203
| +298% | +$2.95M | 1.14% | 35 |
|
|
2022
Q3 | $993K | Sell |
3,428
-305
| -8% | -$88.4K | 0.29% | 50 |
|
|
2022
Q2 | $1.05M | Buy |
+3,733
| New | +$1.05M | 0.33% | 44 |
|